Nicolas Dumont

Dr. Nicolas Dumont profile picture.

Associate professor, Rehabilitation department, University of Montreal

Principal Investigator, Musculoskeletal health research axis, Sainte-Justine Hospital research center

Email Nicolas


Dr. Nicolas Dumont obtained his PhD at the Université Laval where he studied the regulatory network between inflammatory cells and skeletal muscles. He did his post-doctoral training at the Ottawa Hospital Research Institute in Dr. Michael Rudnicki’s lab, where he studied muscle stem cell defects in Duchenne Muscular Dystrophy. Dr. Dumont became an assistant professor at the Université de Montréal in 2016, and he established his lab at the Sainte-Justine hospital research center. His research program is divided in 3 axes: 1) characterizing the intrinsic mechanisms regulating muscle stem cell fate decision during myogenesis, 2) characterizing the impact of rare genetic variants on muscle stem cell function, and 3) investigating novel therapeutic avenues targeting defective muscle stem cells to mitigate muscular dystrophies. Dr. Dumont holds a FRQS Junior-2 award, and his lab is funded by grants from the CIHR, NSERC, ThéCell network, Stem Cell Network, Orphan disease center, AFM-Telethon, and Muscular Dystrophy Canada.

Recent Publications

  1. Zendjebil, S, d'Angelo, L, Doguet, F, Dumont, N, Benamer, H, Fourchy, D et al.. Computed Tomography/Fluoroscopy Fusion and 3D Transesophageal Echocardiography-Guided Percutaneous Paravalvular Leak Closure. JACC Case Rep. 2023.5 101690 PMID:36636511
  2. Deprez, A, Orfi, Z, Rieger, L, Dumont, NA. Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies. Biosci Rep. 2023.43 (1) PMID:36538023
  3. Sénéchal, C, Fujita, R, Jamet, S, Maiga, A, Dort, J, Orfi, Z et al.. The adhesion G-protein-coupled receptor Gpr116 is essential to maintain the skeletal muscle stem cell pool. Cell Rep. 2022.41 (7)111645 PMID:36384129
  4. Raad, S, David, A, Sagniez, M, Paré, B, Orfi, Z, Dumont, NA et al.. iPSCs derived from esophageal atresia patients reveal SOX2 dysregulation at the anterior foregut stage. Dis Model Mech. 2022.15 (11) PMID:36317486
  5. Mashinchian, O, De Franceschi, F, Nassiri, S, Michaud, J, Migliavacca, E, Aouad, P et al.. An engineered multicellular stem cell niche for the 3D derivation of human myogenic progenitors from iPSCs. EMBO J. 2022.41 (14)e110655 PMID:35703167
  6. Soulez, M, Tanguay, PL, Dô, F, Dort, J, Crist, C, Kotlyarov, A et al.. ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation. J Cell Physiol. 2022.237 (4)2271-2287 PMID:35141958
  7. Fabre, P, Molina, T, Orfi, Z, Dumont, NA. Assessment of Muscle Function Following hiPSC-Derived Myoblast Transplantation in Dystrophic Mice. Curr Protoc. 2022.2 (1)e356 PMID:35085428
  8. Molina, T, Fabre, P, Dumont, NA. Fibro-adipogenic progenitors in skeletal muscle homeostasis, regeneration and diseases. Open Biol. 2021.11 (12)210110 PMID:34875199
Search PubMed